Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
With a market cap of 352.21B, Merck(MRK) trades at $142.82. The stock has a price-to-earnings ratio of 113.45 and currently yields dividends of 2.40%.
On 2026-10-08, Merck(MRK) stock traded between a low of $141.52 and a high of $144.15. Shares are currently priced at $142.82, which is +0.9% above the low and -0.9% below the high.
Merck(MRK) shares are trading with a volume of 6.35M, against a daily average of 8.62M.
During the past year, Merck(MRK) stock moved between $82.01 at its lowest and $156.92 at its peak.
During the past year, Merck(MRK) stock moved between $82.01 at its lowest and $156.92 at its peak.
MRK News
A Dutch court injunction blocking Merck (MRK) from manufacturing and selling subcutaneous Keytruda in eight European countries puts legal risk around a flagship...
...
Tempus (TEM) announced an expanded, multi-year collaboration to support the potential commercialization of intismeran autogene, a novel, potential first-in-clas...
Analyst ratings
68%
of 31 ratingsMore MRK News
Halozyme Therapeutics (HALO) announced that the specialized Dutch patent court of the Hague has found Merck (MRK) to be infringing one of its MDASE patents, EP...
Recent Merck news spans multiple therapeutic areas, including an FDA approval for WELIREG plus LENVIMA in advanced renal cell carcinoma, an FDA label update for...
In the latest trading session, Merck (MRK Quick QuoteMRK - Free Report) closed at $141.94, marking a +1.72% move from the previous day. The stock exceeded...
Technology Vaxcyte Catapults After Going Toe-To-Toe With Pfizer, Merck In Vaccine Study Licensing Vaxcyte (PCVX) stock catapulted to a nearly two-year high Mond...
JPMorgan raised the firm’s price target on Merck (MRK) to $165 from $150 and keeps an Overweight rating on the shares ahead of the Q3 report on October 29. The...
Wedbush analyst David Nierengarten raised the firm’s price target on Shattuck Labs (STTK) to $14 from $11 and keeps an Outperform rating on the shares. The firm...
Merck (NYSE:MRK) reported positive Phase 2b data for tulisokibart in moderate to severe hidradenitis suppurativa patients. The trial showed both medium and hig...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.